Floating Button
Home Capital Investing strategies

Raffles Medical Group remains in the pink of health

Samantha Chiew
Samantha Chiew • 4 min read
Raffles Medical Group remains in the pink of health
'Buy' calls all around for Raffles Medical. Photo: Raffles Medical Group
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Raffles Medical Group (RMG) reported earnings of $70.6 million for its FY2025 ended Dec 31, 2025, an increase of 13.4% y-o-y, due to the combination of better performance from the hospital services and insurance businesses, as well as fair value gains on investment properties. Revenue increased 1.8% y-o-y to $765.3 million, underpinned by higher patient volumes, improved average bill sizes and operational efficiencies.

Meanwhile, cash flow remains strong at $310.8 million, providing it with the flexibility to support strategic growth initiatives while continuing to return value to shareholders. The company plans to pay a final dividend of 3 cents per share, equivalent to a payout ratio of 84%, and an improvement over FY2024’s 2 cents. Besides reflecting better earnings, the higher dividend is to help mark the company’s 50th anniversary.

For founder and executive chairman Dr Loo Choon Yong, he is eager to lead an even larger entity than the sole clinic he started. Besides focusing on growing his existing markets of Singapore, China, Vietnam, Cambodia, Japan and Hong Kong, Loo is eyeing further expansion.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.